[
  {
    "ts": "2026-02-19T12:22:00+00:00",
    "headline": "$19.8 Billion Cell and Gene Therapy Tools & Reagents Market Outlook, 2030 Featuring Thermo Fisher Scientific, Cytiva (Danaher), Merck, Miltenyi Biotec, Sartorius and More",
    "summary": "Emerging technologies, increasing focus on R&D, and a growing demand in treating previously incurable diseases present significant opportunities across diverse applications and regions Cell & Gene Therapy Tools and Reagents Market Cell & Gene Therapy Tools and Reagents Market Dublin, Feb. 19, 2026 (GLOBE NEWSWIRE) -- The \"Cell and Gene Therapy Tools and Reagents: Global Markets\" has been added to ResearchAndMarkets.com's offering.The global market for cell and gene therapy tools and reagents is",
    "url": "https://finance.yahoo.com/news/19-8-billion-cell-gene-122200041.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "9d5176e9-d523-318b-be9c-33f1e5f870c4",
      "content": {
        "id": "9d5176e9-d523-318b-be9c-33f1e5f870c4",
        "contentType": "STORY",
        "title": "$19.8 Billion Cell and Gene Therapy Tools & Reagents Market Outlook, 2030 Featuring Thermo Fisher Scientific, Cytiva (Danaher), Merck, Miltenyi Biotec, Sartorius and More",
        "description": "",
        "summary": "Emerging technologies, increasing focus on R&D, and a growing demand in treating previously incurable diseases present significant opportunities across diverse applications and regions Cell & Gene Therapy Tools and Reagents Market Cell & Gene Therapy Tools and Reagents Market Dublin, Feb. 19, 2026 (GLOBE NEWSWIRE) -- The \"Cell and Gene Therapy Tools and Reagents: Global Markets\" has been added to ResearchAndMarkets.com's offering.The global market for cell and gene therapy tools and reagents is",
        "pubDate": "2026-02-19T12:22:00Z",
        "displayTime": "2026-02-19T12:22:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/bcb891829ad73080a96d7205b49b32ab",
          "originalWidth": 600,
          "originalHeight": 400,
          "caption": "Cell & Gene Therapy Tools and Reagents Market",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lCwnbT5CutkKQOCxNZL60Q--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/bcb891829ad73080a96d7205b49b32ab.cf.webp",
              "width": 600,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Yn.LMVeb3C8KN5SOS7qSFA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/bcb891829ad73080a96d7205b49b32ab.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/19-8-billion-cell-gene-122200041.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/19-8-billion-cell-gene-122200041.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TMO"
            },
            {
              "symbol": "DHR"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "SARTF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-19T16:05:00+00:00",
    "headline": "Masimo's Board Backs Danaher's $9.9B Cash Acquisition Proposal",
    "summary": "MASI will be acquired by Danaher for $9.9B in cash, sending shares soaring as the medtech firm prepares to join DHR's Diagnostics segment.",
    "url": "https://finance.yahoo.com/news/masimos-board-backs-danahers-9-160500802.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "215a2f22-bf60-3a44-8501-f90aab156510",
      "content": {
        "id": "215a2f22-bf60-3a44-8501-f90aab156510",
        "contentType": "STORY",
        "title": "Masimo's Board Backs Danaher's $9.9B Cash Acquisition Proposal",
        "description": "",
        "summary": "MASI will be acquired by Danaher for $9.9B in cash, sending shares soaring as the medtech firm prepares to join DHR's Diagnostics segment.",
        "pubDate": "2026-02-19T16:05:00Z",
        "displayTime": "2026-02-19T16:05:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/6ddc1ac8527dad9395e87db2ec9458d3",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QKCCdLL0KBMaEP.VndDSEg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/6ddc1ac8527dad9395e87db2ec9458d3.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/IyD8UmOeo9XOZyL5DDFooA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/6ddc1ac8527dad9395e87db2ec9458d3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/masimos-board-backs-danahers-9-160500802.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/masimos-board-backs-danahers-9-160500802.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DHR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]